Piero Galieni

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Nongastrointestinal Low-Grade Mucosa-Associated Lymphoid Tissue Lymphoma: Analysis of 75 Patients

Pier Luigi Zinzani, Massimo Magagnoli, Piero Galieni et al. · Journal of Clinical Oncology · 1999 · 282 citations

Medicine, Hematology, Oncology +10

Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Corrado Girmenia, Gian María Rossolini, Alfonso Piciocchi et al. · Bone Marrow Transplantation · 2014 · 188 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey

Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi et al. · Clinical Infectious Diseases · 2017 · 160 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

Giuseppe Visani, Lara Malerba, Pietro Maria Stefani et al. · Blood · 2011 · 136 citations · Full text

Medicine, Oncology, Pharmacology +13